Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kangmei Pharmaceutical Co Ltd to Set Up New Subsidiary


Monday, 17 Jun 2013 08:00pm EDT 

Kangmei Pharmaceutical Co Ltd announced that it has decided to set up a wholly owned subsidiary, which will be engaged in marketing of Chinese herbal medicines and sales of herbal medicines, based in Qinghai, with a registered capital of RMB 30 million.